Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream	The University of Queensland, Australia	Ongoing	Meropenem / Piperacillin-Tazocin	4	MED0313	King Fahad Specialist Hospital (Dammam)
Evaluation of Changes in Quality of Life and Socio-Professional Status in Subjects with Moderate to Severe Plaque Psoriasis Treated with Adalimumab in Routine Medical Practice - EQUIPE	AbbVie	Completed	Adalimumab	4	10241	King Faisal Specialist Hospital and Research Center (Riyadh)
XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study	Bayer	Ongoing	Xarelto	4	16691	Prince Sultan Cardiac Center (Qassim), Abdul Rahman Al-Mishari Hospital (Riyadh), King Fahad Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh), Dallah Hospital (Riyadh), Prince Sultan Cardiac Center (Riyadh)
Monitoring of Unfractionated Heparin Therapeutic Level by Using Activated Partial Thromboplastin Time Versus Anti factor Xa Levels	KAIMRC	Ongoing	Multiparin	4	RC15/022/R	King Abdulaziz Medical City NG (Riyadh)
Impact on glycaemic control of the intensification of insulin therapy proposed by ADA/EASD guidelines with insulin glargine as pasal insulin plus a single daily dose of insulin glulisine at main meal : Basal plus strategy in real life	Sanofi	Ongoing	Lantus®/Apidra®	4	APIDR_L_05185	King Abdulaziz University Hospital (Jeddah), Armed Forces Hospital (Taif)
Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C	Roche	Ongoing	Pegasys	4	MV25599	King Abdullah Medical City (Makkah), King Faisal Specialist Hospital and Research Center (Riyadh), Prince Sultan Military Medical City (Riyadh)
A Prospective Multicentre Randomised Controlled Trial of Early Goal Directed Sedation Compared with Standard Care in Mechanically Ventilated Patients in Intensive Care	Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG)	Ongoing	Dexmedetomidine	4	RC 12-079	King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)
A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)	Novartis	Ongoing	Everolimus	4	CRAD001A2433	Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
Prevalence and Patient Experience with Condylomas Study in Saudi Arabia	Merck Serono	Ongoing	N/A	4	PREPEC	King Abdulaziz University Hospital (Jeddah), Prince Sultan Military Medical City (Riyadh) , King Fahad Medical City (Riyadh)
Global Registry Program on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation.	Boehringer Ingelheim	Ongoing	Dabigatran (dabigatran etexilate = prodrug)	4	1160.129	King Fahad Medical City (Riyadh), King Faisal Hospital (Taif) , King Salman Bin AbdulAziz Hospital (Riyadh), King Fahad Hospital (Hofuf), Armed Forces Hospital (Southern Region) , Armed Forces Hospital (North West Region)